The document is an amendment to the Notice of Funding Opportunity (NOFO) No. 72061324RFA00001, issued by USAID for the "Scaling Up Prevention, Oversight, Reach and Treatment of Tuberculosis in Zimbabwe" program. It primarily addresses inquiries received regarding the funding opportunity issued on June 28, 2024. The amendment maintains the original intent and parameters of the NOFO, while providing clarifications on specific questions about eligibility, procurement, and implementation.
Key issues addressed include the scope of minor procurements allowed under the grant, expectations for district coverage, roles of international and local partners in consortiums, and the limitations on clinical trials and trial-related activities. Additionally, it underscores the importance of leveraging previous USAID investments and the requirement for organizational performance histories from prime applicants and consortium partners. Other topics include application formatting, evaluation criteria, and eligibility, particularly emphasizing that international partners can collaborate but may not apply as prime applicants.
This amendment demonstrates USAID's ongoing support for TB control efforts in Zimbabwe while ensuring transparency and guidance to prospective applicants navigating the funding process.
USAID is offering a funding opportunity for local entities through the Notice of Funding Opportunity (NOFO) 72061324RFA00001 to implement the SUPPORT-TB Activity in Zimbabwe, aiming to scale up the prevention, oversight, reach, and treatment of tuberculosis (TB). The deadline for submissions is July 31, 2024. The program addresses significant challenges in TB case detection and treatment, particularly focusing on individuals affected by TB and drug-resistant TB (DR-TB).
The activity aligns with Zimbabwe's National Strategic Plan and aims to improve TB outcomes by enhancing case detection, strengthening case management, preventing new infections, and bolstering local systems. Eligible applicants must be Zimbabwean local organizations.
The anticipated budget is $29 million over five years, and the project will emphasize integration with other health programs, particularly HIV. Key performance indicators will focus on increasing TB notifications and improving treatment success rates. USAID seeks a collaborative approach with local partners to ensure sustainability and effective service delivery, embracing adaptive management to respond to evolving health needs within Zimbabwe.